{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"cellular-phase-chronic-idiopathic-myelofibrosis","columns":[],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":[],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"not available","narrativeSourceChanges":[],"records":0,"sourceGroups":{}},"features":[],"ledeHtml":"Primary myelofibrosis characterized by bone marrow hypercellularity and the presence of atypical megakaryocytes. There is no increase in the percentage of myeloblasts and no significant increase in reticulin or collagen fibrosis in the bone marrow.","mondoId":"MONDO:0004463","node":{"canonicalSlug":"cellular-phase-chronic-idiopathic-myelofibrosis","comparisons":[],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"cellular phase chronic idiopathic myelofibrosis","paragraphs":["Primary myelofibrosis characterized by bone marrow hypercellularity and the presence of atypical megakaryocytes. There is no increase in the percentage of myeloblasts and no significant increase in reticulin or collagen fibrosis in the bone marrow."],"scope":"exact","source":"MONDO","upstream":"NCIT:P378","url":"https://monarchinitiative.org/MONDO:0004463"},"ownColumnKeys":[],"publication":"published","relationships":[{"kind":"parent","label":"primary myelofibrosis","mondoId":"MONDO:0009692","slug":"primary-myelofibrosis"},{"kind":"parent","label":"idiopathic disease","mondoId":"MONDO:0700007","slug":null}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Public source record is not available in the frozen inputs","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/24019"}],"translation":"published"},"records":[],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0004463\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>NCIT:P378</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Primary myelofibrosis characterized by bone marrow hypercellularity and the presence of atypical megakaryocytes. There is no increase in the percentage of myeloblasts and no significant increase in reticulin or collagen fibrosis in the bone marrow.</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0004463\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"cellular-phase-chronic-idiopathic-myelofibrosis","sourceDocuments":[{"name":"MONDO: cellular phase chronic idiopathic myelofibrosis","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0004463"}],"sourceNote":"","synonyms":["chronic idiopathic myelofibrosis, cellular phase","chronic idiopathic myelofibrosis, Prefibrotic stage","PMFPES","Prefibrotic/Early Primary myelofibrosis","primary myelofibrosis, Prefibrotic stage","primary myelofibrosis, Prefibrotic/early stage"],"takeawayHtml":"","title":"cellular phase chronic idiopathic myelofibrosis"},"schemaVersion":1}
